Search | IOVS | ARVO Journals

Showing 1 – 20 of 74

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2025

Non-inferiority of Ketamine-Midazolam Compared to Fentanyl-Midazolam for Sedation in Phacoemulsification: A Randomized Double-Blind Crossover Study.

Adriano Cypriano Faneli; Ricardo Danilo Chagas Oliveira; Pablo Amado; Rodrigo Amaral Torres; Cristina Muccioli

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):5031.

ARVO Annual Meeting Abstract June 2025

Baseline and early treatment response variables associated with faricimab durability in treatment-naïve nAMD: TENAYA/LUCERNE post hoc analyses

Colin S Tan; Roberto Gallego-Pinazo; Adrian Hock Chaun Koh; John D Pitcher; Nicholas Dagincourt; Ming Yang; Shriji Patel; Philippe Margaron

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):690.

ARVO Annual Meeting Abstract June 2025

Faricimab for Polypoidal Choroidal Vasculopathy: Week 16 Results From the Phase 3b/4 SALWEEN Trial

Junyeop Lee; Gemmy Cheung; Shih-Jen Chen; Tomohiro Iida; Adrian Hock Chaun Koh; Won Ki Lee; Paisan Ruamviboonsuk; Xiaodong Sun; Yasuo Yanagi; Ruobing Bai; Philippe Margaron; Anh Nguyen Duc; Timothy Y Y Lai

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):1859.

ARVO Annual Meeting Abstract June 2025

Anatomical and Functional Outcomes of Internal Limiting Membrane Flap Versus Conventional Peeling Technique for Primary Repair of Idiopathic Full-thickness Macular Holes: a Registry-based Cohort Study

Zi Jin; Ee Lin Ong; Mohammad Amin Honardoost; Arul Earnest; Rohan Essex; Weng Onn Chan; Fred Kuanfu Chen; Penelope J Allen; abhishek sharma; Gurmit Uppal; Adrian Tien-Chin Fung

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):1914.

ARVO Annual Meeting Abstract June 2025

Global real-world clinical and anatomical outcomes with faricimab in treatment-naïve patients with nAMD or DME from a prospective non-interventional study: The VOYAGER study

Robyn H Guymer; Steffen Schmitz-Valckenberg; Clare Bailey; Voraporn Chaikitmongkol; Varun Chaudhary; Gloria Chi; Amanda Downey; Robert P Finger; Adrian Hock Chaun Koh; Susumu Ishida; Monica Lövestam-Adrian; Mariacristina Parravano; José Domingo Luna; Veeral Sheth; Beijue Shi; Eric H. Souied; Diane Uschner

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):3111.

ARVO Annual Meeting Abstract June 2024

Possible Treatment Approach for Retinitis Pigmentosa by Targeting Inhibition of PTEN in the PI3K-Akt Signaling Pathway

Pamella C Morello; Amanda C Morello; Dillan Cunha Amaral; Adriano Cypriano Faneli; Denisse J Mora-Paez; Jaime Guedes; Sergio Morello Jr

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3101.

ARVO Annual Meeting Abstract June 2024

Enhancing Corneal Diagnostics: The Emergence of Fluorescein Corneography for Detecting Epithelial Corneal Erosions

Massimiliano Borselli; Costanza Rossi; Adriano Carnevali; Vincenzo Scorcia; Giuseppe Giannaccare

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5908.

ARVO Annual Meeting Abstract June 2024

Photobiomodulation for Dry Age Related Macular Degeneration and Beyond: Expanding Horizons of this Promising Technology

Costanza Rossi; Massimiliano Borselli; CLAUDIO IOVINO; Adriano Carnevali; Vincenzo Scorcia; Giuseppe Giannaccare

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4416.

ARVO Annual Meeting Abstract June 2024

Extended treatment outcomes and the potential for Q20W dosing with faricimab in nAMD: a post hoc analysis of the pivotal TENAYA/LUCERNE trials

Philip Storey; Aude Ambresin; Adrian Hock Chaun Koh; Michael Singer; Lauren Hill; Aachal Kotecha; Philippe Margaron

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):254.

ARVO Annual Meeting Abstract June 2024

Transcriptomic profile of primary human meibomian gland cells exposed to PM2.5 diesel exhaust particles

Ha T. Duong; Minh Anh Thu Phan; Michele Madigan; Adrian V Cioanca; Blanka Golebiowski

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3873.

ARVO Annual Meeting Abstract June 2024

Association between Fundoscopic Lesions and CNS Injuries Identified in Children with Congenital Zika Syndrome

Leticia Freitas de Aquino; Marcos Adriano Garcia Campos; Paulo Henrique Simoes da Silva; Elaine de Paula Fiod Costa

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):100.

Retina December 2023

Intravitreal Brolucizumab for Pachychoroid Neovasculopathy Associated With Chronic Central Serous Chorioretinopathy

PDF

Marianna Carosielli; Adriano Carnevali; Matteo Fallico; Enza Pirozzi; Flavia Chiosi; Argyrios Chronopoulos; Pasquale Cucciniello; Marzia Affatato; Giuseppe Rapino; Roberto dell'Omo; on behalf of the BROCS study group, BROCS (BROlucizumab for the treatment of Central Serous chorioretinopathy) study group†
TAGS: brolucizumab, central serous chorioretinopathy, eye, injections, anti-vascular endothelial growth factor therapy
Trans. Vis. Sci. Tech.. 2023; 12(12):17. https://doi.org/10.1167/tvst.12.12.17

ARVO Annual Meeting Abstract June 2023

Neutrophil heterogeneity in choroidal neovascularization: insights from single-cell RNA sequencing

Nasir Uddin; Adrian Cioanca; Simon Gross; Alice Brandli; Riccardo Natoli; Erica Lucy Fletcher; Matt Rutar

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1919.

ARVO Annual Meeting Abstract June 2022

Evaluating the Qualitative Features of Occular Surface Dry Eye Disease using a Novel Confocal Microscopy Imaging Protocol

Adrian C Tsang; Jeremy Nortey; Sarah E Lopez; John Alexander Gonzales; Jeremy D Keenan

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1229 – A0229.

ARVO Annual Meeting Abstract June 2022

Association of fundus autofluorescence changes and pachydrusen in central serous chorioretinopathy and polypoidal choroidal vasculopathy

Timothy Y Y Lai; Ziqi Tang; Adrian C W Lai; Ricky Y K Lai; Carol Y. Cheung

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3753 – F0174.

Glaucoma January 2022

Is Genetic Risk for Sleep Apnea Causally Linked With Glaucoma Susceptibility?

PDF

Nathan Ingold; Adrian I. Campos; Xikun Han; Jue-Sheng Ong; Puya Gharahkhani; David A. Mackey; Miguel E. Rentería; Matthew H. Law; Stuart MacGregor
TAGS: disease susceptibility, glaucoma, obstructive sleep apnea, sleep apnea syndromes, genetic risk
Invest. Ophthalmol. Vis. Sci.. 2022; 63(1):25. https://doi.org/10.1167/iovs.63.1.25

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2021

Does bright light exposure affect in vitro choroid melanoma viability and secretion of pro-inflammatory chemokines?

Chieh-Lin (Stanley) Wu; V. Adrian Cioanca; Ling Zhu; Yingying Chen; Riccardo Carlo Natoli; R. Max Conway; Michele C Madigan

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2865.

ARVO Annual Meeting Abstract June 2021

Melanocytes, Inflammation and Responses in the Human Choroidal Microenvironment

Michele C Madigan; Chieh-Lin Wu; Martine J Jager; R. Max Conway; Riccardo Carlo Natoli; V. Adrian Cioanca

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2840.

ARVO Annual Meeting Abstract July 2019

Visual and expanded anatomical outcomes for brolucizumab versus aflibercept in patients with neovascular AMD: 96-week data from HAWK and HARRIER

Rishi P Singh; Charles Clifton Wykoff; Ramin Tadayoni; Yuichiro Ogura; Adrian H C Koh; Frank G Holz; Robin Hamilton; David Tanzer; Georges Weissgerber; Jahangir Alam; Pravin U Dugel

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5194.

ARVO Annual Meeting Abstract July 2019

Is pterygium an indicator of an increased risk of developing cutaneous melanoma? – Retrospective study in the UK

Jia Yu Yu Ng; Adriana Chilinska; Sayali Pradhan; Martina Althaus; Nusayhah Gopee; David Brass; James Langtry; Thomas Oliphant; Eric Barnes; Francisco C Figueiredo

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3573.

1 2 3 4

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Non-inferiority of Ketamine-Midazolam Compared to Fentanyl-Midazolam for Sedation in Phacoemulsification: A Randomized Double-Blind Crossover Study.

Baseline and early treatment response variables associated with faricimab durability in treatment-naïve nAMD: TENAYA/LUCERNE post hoc analyses

Faricimab for Polypoidal Choroidal Vasculopathy: Week 16 Results From the Phase 3b/4 SALWEEN Trial

Anatomical and Functional Outcomes of Internal Limiting Membrane Flap Versus Conventional Peeling Technique for Primary Repair of Idiopathic Full-thickness Macular Holes: a Registry-based Cohort Study

Global real-world clinical and anatomical outcomes with faricimab in treatment-naïve patients with nAMD or DME from a prospective non-interventional study: The VOYAGER study

Possible Treatment Approach for Retinitis Pigmentosa by Targeting Inhibition of PTEN in the PI3K-Akt Signaling Pathway

Enhancing Corneal Diagnostics: The Emergence of Fluorescein Corneography for Detecting Epithelial Corneal Erosions

Photobiomodulation for Dry Age Related Macular Degeneration and Beyond: Expanding Horizons of this Promising Technology

Extended treatment outcomes and the potential for Q20W dosing with faricimab in nAMD: a post hoc analysis of the pivotal TENAYA/LUCERNE trials

Transcriptomic profile of primary human meibomian gland cells exposed to PM2.5 diesel exhaust particles

Association between Fundoscopic Lesions and CNS Injuries Identified in Children with Congenital Zika Syndrome

Intravitreal Brolucizumab for Pachychoroid Neovasculopathy Associated With Chronic Central Serous Chorioretinopathy

Neutrophil heterogeneity in choroidal neovascularization: insights from single-cell RNA sequencing

Evaluating the Qualitative Features of Occular Surface Dry Eye Disease using a Novel Confocal Microscopy Imaging Protocol

Association of fundus autofluorescence changes and pachydrusen in central serous chorioretinopathy and polypoidal choroidal vasculopathy

Is Genetic Risk for Sleep Apnea Causally Linked With Glaucoma Susceptibility?

Does bright light exposure affect in vitro choroid melanoma viability and secretion of pro-inflammatory chemokines?

Melanocytes, Inflammation and Responses in the Human Choroidal Microenvironment

Visual and expanded anatomical outcomes for brolucizumab versus aflibercept in patients with neovascular AMD: 96-week data from HAWK and HARRIER

Is pterygium an indicator of an increased risk of developing cutaneous melanoma? – Retrospective study in the UK

To View More...

You must be signed into an individual account to use this feature.